Lv1
70 积分 2025-07-28 加入
A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer
1个月前
已完结
Integrating PD-L1-targeted radioligand with protein degradation for precision tumor theranostics
1个月前
已完结
Chapter 2 - Brain metastases: epidemiology
2个月前
已关闭
Targeting Prostatic Acid Phosphatase in Prostate Cancer: Roadmap on How To Venture Above and Beyond Prostate-specific Membrane Antigen with ACP3 Theranostics
2个月前
已完结
Advances in the development of large neutral amino acid transporter 1 (LAT1) substrate analogues and inhibitors for the delivery of drugs and radiopharmaceuticals
5个月前
已完结
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
7个月前
已完结
Biodistribution and Radiation Dosimetry of [68Ga]Ga-RAYZ-8009, a Glypican 3–Targeting Compound for Imaging of Hepatocellular Carcinoma
11个月前
已关闭
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
1年前
已完结
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs’ development
1年前
已完结
Nectin-4 expression patterns and therapeutics in oncology
1年前
已完结
皖公网安备34019202002308
